Arena Pharmaceuticals, Inc. (ARNA)

[groverisproud]

Another thought is also that a delay is not a denial...unless the FDA summarily rejects Lorcaserin (which they definitely could not do without MAJOR backlash), they would delay it and the stock price would drop but probably not dramatically (judging by the effect that had on VVUS's pps). My sense is that the upside is really huge here, but the downside is very limited and we will receive several clues that the stock price will tank dramatically before it actually does. Does my theory hold water?